Enzolytics Inc (ENZC)

[sspalmo]

"Zimbler has apparently not been associated with ENZC in years and not mentioned at all since the merger with BioClonetics in November 2020. I don't see any current payments to him. Where are you getting that?"

He is mentioned in every quarterly and annual that ENZC has filed.
Page 44 of the latest quarterly report.
https://www.otcmarkets.com/otcapi/company/financial-report/403184/content

As to his to him not having association with ENZC for years, I have no evidence of that. Kelli Austin appeared to have no affiliation with Harry or Enzolytics prior to the promissory convertible note issued 11/1/22 or the SAGA deal announced in 2023. Upon taking a deeper look there is a history between Kelli and Harry that goes back nearly a decade. I have not seen mention of Billy Ray in the filings but did find that he is linked to Enzolytics.

"Looking back at the notes to the financials, it looks like the balance due to him grew over several years in varying amounts, such as 14-20K per year to the final and current balance of $142,646 by the end of 2018 with an increase of only $1.1K since 2017. The company was doing business as ECO-PETROLEUM SOLUTIONS, INC. during most of that time, filing as Enzolytics, Inc. for the first time in 2018."

I may have misspoken about him being paid annually, and you may be correct that this is a debt that is just growing in value. I can't tell for sure because there really wasn't any transparency with their filings. If this debt was accrued prior to the Enzolytics and BioClonetics merger shouldn't this be debt of the predecessor? Why is it listed as owed by the current company and not a responsibility of Robustomed?
https://www.otcmarkets.com/otcapi/company/financial-report/403184/content

Note 6. Related Party Transactions
As of March 31, 2024 and December 31, 2023, the Company owed to Directors, officers, and
stockholders of the Company $353,101 and $343,101, respectively. The amounts are unsecured,
noninterest bearing, and have no terms for repayment. The individual amounts owed to Directors, officers
and stockholders are presented as follows: